Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

METABOLISM AND EXCRETION OF ERLOTINIB, A SMALL MOLECULE INHIBITOR OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE, IN HEALTHY MALE VOLUNTEERS

Jie Ling, Kim A. Johnson, Zhuang Miao, Ashok Rakhit, Michael P. Pantze, Marta Hamilton, Bert L. Lum and Chandra Prakash
Drug Metabolism and Disposition March 2006, 34 (3) 420-426; DOI: https://doi.org/10.1124/dmd.105.007765
Jie Ling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim A. Johnson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhuang Miao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashok Rakhit
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael P. Pantze
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Hamilton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bert L. Lum
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chandra Prakash
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 34 no. 3 420-426
DOI 
https://doi.org/10.1124/dmd.105.007765
PubMed 
16381666

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received October 10, 2005
  • Accepted December 19, 2005
  • Published online February 21, 2006.

Article Versions

  • Earlier version (December 28, 2005 - 07:06).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Jie Ling,
  2. Kim A. Johnson,
  3. Zhuang Miao,
  4. Ashok Rakhit,
  5. Michael P. Pantze,
  6. Marta Hamilton,
  7. Bert L. Lum and
  8. Chandra Prakash
  1. Department of Pharmacokinetic, Pharmacodynamic, and Bioanalytical Sciences, Genentech Incorporated, South San Francisco, California (J.L., B.L.L.); Departments of Pharmacokinetics, Dynamics & Metabolism, Pfizer Global Research and Development, Groton, Connecticut (K.A.J., Z.M., C.P.); Hoffmann-La Roche Pharmaceuticals, Nutley, New Jersey (A.R., M.P.P.); and OSI Pharmaceuticals, Boulder, Colorado (M.H.)
  1. Address correspondence to:
    Dr. Bert L. Lum, Department of Pharmacokinetic and Pharmacodynamic Sciences, Genentech, Inc., 1 DNA Way (MS-70), South San Francisco, CA 94080. E-mail: blum{at}gene.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 201734717
Sep 201725523
Oct 201745618
Nov 201796739
Dec 201788126
Jan 2018175316
Feb 2018183918
Mar 201867820
Apr 201877828
May 201876425
Jun 201857225
Jul 201806033
Aug 201814434
Sep 201834724
Oct 2018124724
Nov 2018115831
Dec 2018662322
Jan 201967124
Feb 2019371316
Mar 2019461010
Apr 201952104
May 20193897
Jun 20194997
Jul 20194075
Aug 201940162
Oct 2019915119
Nov 201951126
Dec 20193311211
Jan 202056984
Feb 202044711
Mar 20204267
May 20207843
Jun 2020113154
Jul 20203344
Aug 20205266
Sep 202024102
Oct 20206133
Nov 20204789
Dec 20205686
Jan 202169199
Feb 2021551610
Mar 202152168
Apr 202141710
May 202168124
Jun 20214796
Jul 20216698
Aug 2021251310
Sep 20214953
Oct 2021402012
Nov 20216168
Dec 20215794
Jan 20224276
Feb 20224482
Mar 20222121
Apr 20224244
May 202261107
Jun 20225451
Jul 20225236
Aug 20223663
Sep 202259143
Oct 202242102
Nov 20225897
Dec 20223062
Jan 20236796
Feb 20235669
Mar 20237351

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 34 (3)
Drug Metabolism and Disposition
Vol. 34, Issue 3
1 Mar 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
METABOLISM AND EXCRETION OF ERLOTINIB, A SMALL MOLECULE INHIBITOR OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE, IN HEALTHY MALE VOLUNTEERS
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

METABOLISM AND EXCRETION OF ERLOTINIB, A SMALL MOLECULE INHIBITOR OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE, IN HEALTHY MALE VOLUNTEERS

Jie Ling, Kim A. Johnson, Zhuang Miao, Ashok Rakhit, Michael P. Pantze, Marta Hamilton, Bert L. Lum and Chandra Prakash
Drug Metabolism and Disposition March 1, 2006, 34 (3) 420-426; DOI: https://doi.org/10.1124/dmd.105.007765

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

METABOLISM AND EXCRETION OF ERLOTINIB, A SMALL MOLECULE INHIBITOR OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE, IN HEALTHY MALE VOLUNTEERS

Jie Ling, Kim A. Johnson, Zhuang Miao, Ashok Rakhit, Michael P. Pantze, Marta Hamilton, Bert L. Lum and Chandra Prakash
Drug Metabolism and Disposition March 1, 2006, 34 (3) 420-426; DOI: https://doi.org/10.1124/dmd.105.007765
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • Antibiotics Induce Changes in the Expression of Rat DPGs
  • Metabolism of Efavirenz by P450s and UGTs in the Brain
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics